scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ATHEROSCLEROSIS.2008.02.034 |
P698 | PubMed publication ID | 18433756 |
P50 | author | Alexander J. Szalai | Q42706107 |
Hwee Teoh | Q53079182 | ||
P2093 | author name string | Subodh Verma | |
Paul E Szmitko | |||
Adrian Quan | |||
Michael E Ward | |||
Guilin Wang | |||
Sam Tirgari | |||
Fina Lovren | |||
P433 | issue | 2 | |
P921 | main subject | endothelium | Q111140 |
overexpression | Q61643320 | ||
P304 | page(s) | 318-325 | |
P577 | publication date | 2008-03-20 | |
P1433 | published in | Atherosclerosis | Q4813570 |
P1476 | title | Impaired endothelial function in C-reactive protein overexpressing mice | |
P478 | volume | 201 |
Q34095488 | Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke |
Q34858081 | Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients |
Q64057283 | Association between serum high-sensitivity C-reactive protein levels and erectile dysfunction: a cross-sectional study of Chinese male population |
Q47369620 | C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study. |
Q37245114 | C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: role of peroxynitrite |
Q37422600 | C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction |
Q54439738 | C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice. |
Q33961757 | C-reactive protein-mediated vascular injury requires complement. |
Q48024005 | Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice |
Q35547019 | Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function |
Q30645084 | Discordant association of C-reactive protein with clinical events and coronary luminal narrowing in postmenopausal women: data from the Women's Angiographic Vitamin and Estrogen (WAVE) study. |
Q37392562 | Diurnal variability of C-reactive protein in obstructive sleep apnea |
Q36784552 | Effect of sulfasalazine on inflammation and endothelial function in patients with established coronary artery disease. |
Q34698229 | Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome |
Q27021449 | Fcγ receptors and ligands and cardiovascular disease |
Q34066540 | Human C-reactive protein and the metabolic syndrome |
Q37327619 | Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo |
Q84755022 | Hypertension and C-reactive protein |
Q38447666 | Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression |
Q48017162 | Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women |
Q43060919 | Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance |
Q37861626 | PAI-1 in tissue fibrosis |
Q54654762 | Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid–induced endothelial dysfunction |
Q28676262 | Pentraxins: structure, function, and role in inflammation |
Q40799557 | Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment |
Q33788524 | Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome |
Q36783729 | Should C-reactive protein be a target of therapy? |
Q37144130 | The evolving role of C-reactive protein in atherothrombosis |
Q35182082 | The long pentraxin PTX3 promotes fibrocyte differentiation |
Q48321973 | The relation between Lp-PLA2 levels with periodic limb movements |
Q34948315 | The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk |
Search more.